Andrew L. Laslett

Characterization and culture of human embryonic stem cells.

Isolation, characterization, and differentiation of human embryonic stem cells.

CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells.

Transcriptional analysis of early lineage commitment in human embryonic stem cells.

Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells.

Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling.

A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells.

Restricted ethnic diversity in human embryonic stem cell lines.

Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors.

Preparation of defined human embryonic stem cell populations for transcriptional profiling.

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Generation of induced pluripotent stem cells from human kidney mesangial cells.

Flow cytometric analysis of human pluripotent stem cells.

A novel role for an RNA polymerase III subunit POLR3G in regulating pluripotency in human embryonic stem cells.

Deep-transcriptome and ribonome sequencing redefines the molecular networks of pluripotency and the extracellular space in human embryonic stem cells.

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.

Suspended in culture--human pluripotent cells for scalable technologies.

The directed differentiation of human iPS cells into kidney podocytes.

Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.

Cell reprogramming: Into the groove.